Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Assertio

Explore full profile

A leading commercial pharmaceutical company bringing differentiated products to patients

Newark, United StatesFounded 1995Biotech & Life Sciences
Valuation $152M Market cap · 2026
Revenue $119M Latest reported FY
EBITDA $15M Latest reported FY

About Assertio

Assertio Holdings, Inc. is a prominent commercial pharmaceutical company specializing in the development and distribution of branded prescription products. The company focuses on three primary therapeutic areas: neurology, hospital care, and pain and inflammation. Assertio serves a diverse range of clients, including healthcare providers, hospitals, and patients who require specialized medications for chronic and acute conditions. Operating within the pharmaceutical market, Assertio leverages business development strategies such as licensing, mergers, and acquisitions to expand its product portfolio and market reach. The business model is centered around the commercialization of differentiated pharmaceutical products, ensuring compliance with legal and regulatory standards while maintaining high ethical standards. Revenue is generated through the sale of prescription medications, supported by strategic partnerships and a commitment to innovation in therapeutic solutions.

Source: Dealroom company data

At a glance

Status
Listed
Founded
1995
Headquarters
Newark, United States
Listing
IPO 1997
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later5 investors entered at this stage

  • Thomas Weisel Partners
  • RBC Capital Markets
  • Morgan Stanley
  • Pharmakon Holdings
  • Deerfield
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
4.7K monthly visits
across markets
🇺🇸 United States66%
🇮🇳 India12.8%
Top 2 markets shown

Patents

Estimated portfolio value
$70M

27 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Assertio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Assertio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.